Health

Assessing Merck and Moderna’s mRNA cancer vaccine

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 30/10/2026, 13:36:24 UTC.

Briefings

STAT's biotech podcast 'The Readout LOUD' features Andrew Joseph discussing recent cancer data from the European Society for Medical Oncology annual meeting. The episode covers public reactions to Merck and Moderna's mRNA cancer vaccine data, with no specific city or country identified in the source text.

Key points

• STAT's biotech podcast 'The Readout LOUD' features Andrew Joseph to discuss cancer data from the European Society for Medical Oncology annual meeting.
• The episode focuses on public reactions to Merck and Moderna's mRNA cancer vaccine data presented at the meeting.

Context

The episode is part of STAT's biotech podcast 'The Readout LOUD' and features Andrew Joseph discussing the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.

Limitations

The source text does not specify the city, region, or country where the European Society for Medical Oncology meeting took place, nor does it provide specific dates or numbers regarding the vaccine data.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/10/2026, 13:47:42 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiayn3znzhnvrvdnbih4jvbacqtdyvxuhymfg55yi5vnveyj3jqcvq